Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan A Smith

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Vaccine|January 8, 2011
Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategiesKaren Canfell, Ju-Fang Shi, Jie-Bin Lew, et al.
The Lancet. Public Health|May 3, 2021
Cervical screening during the COVID-19 pandemic: optimising recovery strategiesAlejandra Castanon, Matejka Rebolj, Emily Annika Burger, et al.
The Lancet. Public Health|December 19, 2017
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening ProgramJie-Bin Lew, Kate T Simms, Megan A Smith, et al.
BMC Health Services Research|October 6, 2023
The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative studyClaire Bavor, Julia Ml Brotherton, Megan A Smith, et al.
International Journal of Cancer|August 13, 2017
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage countryLouiza S Velentzis, Michael Caruana, Kate T Simms, et al.
Preventive Medicine Reports|May 24, 2023
Implementation of Australia's primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences StudyJulia M L Brotherton, Tracey McDermott, Megan A Smith, et al.
Gynecologic Oncology|July 30, 2020
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventionsKate T Simms, Susan Yuill, James Killen, et al.
Papillomavirus Research (Amsterdam, Netherlands)|September 11, 2019
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer controlKaren Canfell, Jane J Kim, Shalini Kulasingam, et al.
Preventive Medicine Reports|September 2, 2024
Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort studyLouiza S Velentzis, Sam Egger, Jo Waller, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
<i>"So, if she wasn't aware of it, then how would everybody else out there be aware of it?"</i>-Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia's Cervical Screening Program: A Qualitative StudyClaire M Zammit, Nicola S Creagh, Tracey McDermott, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Vaccine|January 8, 2011
Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategiesKaren Canfell, Ju-Fang Shi, Jie-Bin Lew, et al.
The Lancet. Public Health|May 3, 2021
Cervical screening during the COVID-19 pandemic: optimising recovery strategiesAlejandra Castanon, Matejka Rebolj, Emily Annika Burger, et al.
The Lancet. Public Health|December 19, 2017
Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening ProgramJie-Bin Lew, Kate T Simms, Megan A Smith, et al.
BMC Health Services Research|October 6, 2023
The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative studyClaire Bavor, Julia Ml Brotherton, Megan A Smith, et al.
International Journal of Cancer|August 13, 2017
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage countryLouiza S Velentzis, Michael Caruana, Kate T Simms, et al.
Preventive Medicine Reports|May 24, 2023
Implementation of Australia's primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences StudyJulia M L Brotherton, Tracey McDermott, Megan A Smith, et al.
Gynecologic Oncology|July 30, 2020
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventionsKate T Simms, Susan Yuill, James Killen, et al.
Papillomavirus Research (Amsterdam, Netherlands)|September 11, 2019
HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer controlKaren Canfell, Jane J Kim, Shalini Kulasingam, et al.
Preventive Medicine Reports|September 2, 2024
Correlates of intention-to-attend and confirmed cervical screening attendance during the COVID-19 pandemic in Australia: Findings from Compass-PLUS, a prospective cohort studyLouiza S Velentzis, Sam Egger, Jo Waller, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
<i>"So, if she wasn't aware of it, then how would everybody else out there be aware of it?"</i>-Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia's Cervical Screening Program: A Qualitative StudyClaire M Zammit, Nicola S Creagh, Tracey McDermott, et al.
Pageof 10